Eric Allaire
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Eric Allaire has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Pascal Desgranges
University of Paris XII, Henri Mondor Hospital, Paris, France
6 shared publications - Jean-Pierre Becquemin
Department of Vascular Surgery, Henri Mondor Hospital, Créteil, France
5 shared publications - Frédéric Cochennec
Henri Mondor University Hospital, Creteil, France
3 shared publications - Joseph Touma
Henri Mondor University Hospital, Creteil, France
2 shared publications Anne-Marie Bsc Guinault
From *CNRS UMR 7054, Centre de Recherches Chirurgicales, Université Paris XII, UFR de médecine, Hôpital H. Mondor, AP-HP Créteil, France; †Service de Chirurgie Vasculaire et Endocrinienne, Hôpital Henri Mondor, Créteil, France; and ‡INSERM U 430, Hôpital Broussais, Paris, France
1 shared publicationAnne-Marie Guinault
1 shared publication
Latest Publications
- 1 November 2018
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 53, 4-5
Results of Endobypasses with Nitinol Covered Stents for TASC C and D Aorto-iliac Lesions
- 1 November 2018
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 53, 4-5
Results of Endobypasses with Nitinol Covered Stents for TASC C and D Aorto-iliac Lesions
- 11 October 2016
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 38, e2
Results of Cryopreserved Arterial Allografts to Treat Infections of Peripheral Bypasses
- 11 October 2016
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 38, e2
Results of Cryopreserved Arterial Allografts to Treat Infections of Peripheral Bypasses
- 8 March 2016
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 33, 227.e9-227.e12
Treatment of an Abdominal Aortic Aneurysm Infected by Coxiella Burnetii Using a Cryopreserved Allograft
- 8 March 2016
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 33, 227.e9-227.e12
Treatment of an Abdominal Aortic Aneurysm Infected by Coxiella Burnetii Using a Cryopreserved Allograft
- 1 November 2015
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 29 (8) , 1493-1500
Initial Experience with Percutaneous Angioplasty of the Common Femoral Artery in De Novo Stenotic Lesions
- 1 November 2015
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 29 (8) , 1493-1500
Initial Experience with Percutaneous Angioplasty of the Common Femoral Artery in De Novo Stenotic Lesions
- 30 June 2012
- Published by Elsevier in Vascular Pharmacology
- Vol. 56 (5-6) , 342
Mature endothelial cell therapy stabilizes abdominal aortic aneurysm through paracrine mechanisms and recruitment of local vascular cells
- 30 June 2012
- Published by Elsevier in Vascular Pharmacology
- Vol. 56 (5-6) , 342
Mature endothelial cell therapy stabilizes abdominal aortic aneurysm through paracrine mechanisms and recruitment of local vascular cells
- 1 January 2006
- Vol. 190 (1) , 89
[Differentiated thyroid carcinoma--how to improve the long-term results? Twenty-five-year outcomes of 850 patients].
About 4000 people are diagnosed with thyroid carcinoma each year in France and as many as one in three adult patients have thyroid nodules on sonography. Nine in ten cases are differentiated (DTC). DTC may recur in the neck or metastasize very late, and final outcomes should therefore only be assessed after at least 20 years of follow-up. The goals of this study were to provide a reference for the evaluation of other protocols, to evaluate the benefits and risks of radioiodine, and to identify the most effective management option. We examined 25-year outcomes in a series of 850 DTC patients who were operated on and monitored with the same protocols. We used an original classification (Ext-Tg) that includes both the initial extension and the thyroglobulin (Tg) level at the end of initial treatment. The low-risk group, composed of patients with Tg 10 microg/l after remnant ablation. Most patients had total thyroidectomy followed by radioiodine ablation, periodic monitoring adapted to the stage, and suppressive therapy. At 25 years the actuarial rates of cancer-related death among patients with initial stage 1, 2, 3 and 4 disease were respectively 0%, 1,4%, 0% and 46,9%. The overall recurrence rates were respectively 3,6%, 3,8%, 5,3% and 44,5%. The rates of cervical recurrence necessitating surgery were 3,8%, 2,4%, 3,4% and 23,7%. Serious complications of treatment, including radioiodine, were rare. We conclude that:--good long-term results are more likely to be obtained when total thyroidectomy and radioiodine are combined with an early detection of recurrences (before they are visible by traditional imaging methods);--patients must be strictly staged in order to guide the modalities and duration of follow-up, and the Ext-TG classification seems more appropriate than all those which do not consider the Tg level at the end of initial treatment;--in experienced hands the benefits of total surgical ablation of the tumor greatly outweigh the potential risks;--radioiodine is effective and safe when appropriate measures are taken to prevent complications, and the long-term eficacy of surveillance without total body scanning should be verified before being universally adopted;--cost-reduction should focus on diagnosis, screening, and the selection of nodules eligible for surgery, rather than on monitoring of patients with DTC. DTC is thus a paradigm of a disease in which it is possible to optimize the long-term results and to lower costs by monitoring small and non-suspect nodules.
- 1 January 2006
- Vol. 190 (1) , 89
[Differentiated thyroid carcinoma--how to improve the long-term results? Twenty-five-year outcomes of 850 patients].
About 4000 people are diagnosed with thyroid carcinoma each year in France and as many as one in three adult patients have thyroid nodules on sonography. Nine in ten cases are differentiated (DTC). DTC may recur in the neck or metastasize very late, and final outcomes should therefore only be assessed after at least 20 years of follow-up. The goals of this study were to provide a reference for the evaluation of other protocols, to evaluate the benefits and risks of radioiodine, and to identify the most effective management option. We examined 25-year outcomes in a series of 850 DTC patients who were operated on and monitored with the same protocols. We used an original classification (Ext-Tg) that includes both the initial extension and the thyroglobulin (Tg) level at the end of initial treatment. The low-risk group, composed of patients with Tg 10 microg/l after remnant ablation. Most patients had total thyroidectomy followed by radioiodine ablation, periodic monitoring adapted to the stage, and suppressive therapy. At 25 years the actuarial rates of cancer-related death among patients with initial stage 1, 2, 3 and 4 disease were respectively 0%, 1,4%, 0% and 46,9%. The overall recurrence rates were respectively 3,6%, 3,8%, 5,3% and 44,5%. The rates of cervical recurrence necessitating surgery were 3,8%, 2,4%, 3,4% and 23,7%. Serious complications of treatment, including radioiodine, were rare. We conclude that:--good long-term results are more likely to be obtained when total thyroidectomy and radioiodine are combined with an early detection of recurrences (before they are visible by traditional imaging methods);--patients must be strictly staged in order to guide the modalities and duration of follow-up, and the Ext-TG classification seems more appropriate than all those which do not consider the Tg level at the end of initial treatment;--in experienced hands the benefits of total surgical ablation of the tumor greatly outweigh the potential risks;--radioiodine is effective and safe when appropriate measures are taken to prevent complications, and the long-term eficacy of surveillance without total body scanning should be verified before being universally adopted;--cost-reduction should focus on diagnosis, screening, and the selection of nodules eligible for surgery, rather than on monitoring of patients with DTC. DTC is thus a paradigm of a disease in which it is possible to optimize the long-term results and to lower costs by monitoring small and non-suspect nodules.
- Open Access
- 1 January 2005
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 4 (4) , 336-340
Resultados tardios das reconstruções arteriais dos membros inferiores com a utilização de veias portadoras de dilatações varicosas revestidas seletivamente com segmentos protéticos
OBJETIVO: Responder as seguintes questões: 1) o revestimento protético deve ser precedido de uma redução da ectasia? 2) as zonas revestidas apresentam um risco de hiperplasia ou estenose? 3) as zonas não revestidas possuem um risco de dilatação e ruptura? MÉTODOS: Doze pacientes (10 homens e duas mulheres), com idades entre 33 e 77 anos (idade mediana = 68), foram submetidos a pontes em conseqüência de arterite (n = 7), aneurisma poplíteo (n = 4) ou ruptura de prótese (n = 1). As pontes foram fêmoro-poplíteas (n = 8), fêmoro-infra poplíteas (n = 3) e poplíteo-poplítea (n = 1). A safena utilizada foi de forma reversa em nove casos e ex situ devalvuladas em três casos. Os revestimentos foram aplicados em número de um (n = 2), dois (n = 3), três (n = 6) e quatro (n = 1). Todos, exceto um, foram de PTFE. RESULTADOS: Duas pontes ocluíram, uma precocemente por déficit de leito distal e outra 4 anos após a operação. As outras 10 pontes permaneceram pérvias durante o acompanhamento, que variou entre 1 e 11 anos (mediana = 4 anos). Metade dos casos apresentou uma deterioração progressiva do leito distal. No último controle, duas pontes permaneceram pérvias, a despeito de um leito distal desértico. CONCLUSÃO: Os resultados desta série apresentam-se notadamente superiores aos das pontes protéicas descritas na literatura. O revestimento é efetuado facilmente com uma prótese curta de PTFE de parede fina. É inútil reduzir as dilatações antes do revestimento por sutura ou ressecção - anastomose. As zonas situadas sobre a bainha de PTFE não evoluem para estenoses. As zonas intermediárias dilatam-se por vezes moderadamente e sem risco de ruptura.
- 1 January 2005
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 4 (4) , 336-340
Open AccessResultados tardios das reconstruções arteriais dos membros inferiores com a utilização de veias portadoras de dilatações varicosas revestidas seletivamente com segmentos protéticos
OBJETIVO: Responder as seguintes questões: 1) o revestimento protético deve ser precedido de uma redução da ectasia? 2) as zonas revestidas apresentam um risco de hiperplasia ou estenose? 3) as zonas não revestidas possuem um risco de dilatação e ruptura? MÉTODOS: Doze pacientes (10 homens e duas mulheres), com idades entre 33 e 77 anos (idade mediana = 68), foram submetidos a pontes em conseqüência de arterite (n = 7), aneurisma poplíteo (n = 4) ou ruptura de prótese (n = 1). As pontes foram fêmoro-poplíteas (n = 8), fêmoro-infra poplíteas (n = 3) e poplíteo-poplítea (n = 1). A safena utilizada foi de forma reversa em nove casos e ex situ devalvuladas em três casos. Os revestimentos foram aplicados em número de um (n = 2), dois (n = 3), três (n = 6) e quatro (n = 1). Todos, exceto um, foram de PTFE. RESULTADOS: Duas pontes ocluíram, uma precocemente por déficit de leito distal e outra 4 anos após a operação. As outras 10 pontes permaneceram pérvias durante o acompanhamento, que variou entre 1 e 11 anos (mediana = 4 anos). Metade dos casos apresentou uma deterioração progressiva do leito distal. No último controle, duas pontes permaneceram pérvias, a despeito de um leito distal desértico. CONCLUSÃO: Os resultados desta série apresentam-se notadamente superiores aos das pontes protéicas descritas na literatura. O revestimento é efetuado facilmente com uma prótese curta de PTFE de parede fina. É inútil reduzir as dilatações antes do revestimento por sutura ou ressecção - anastomose. As zonas situadas sobre a bainha de PTFE não evoluem para estenoses. As zonas intermediárias dilatam-se por vezes moderadamente e sem risco de ruptura.
- 1 March 2004
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 239 (3) , 417-427
Vascular Smooth Muscle Cell Endovascular Therapy Stabilizes Already Developed Aneurysms in a Model of Aortic Injury Elicited by Inflammation and Proteolysis
Objective: To investigate the efficiency of endovascular smooth muscle cell (VSMC) seeding in promoting healing and stability in already-developed aneurysms obtained by matrix metalloproteases (MMPs)-driven injury. Summary Background Data: VSMCs are instrumental in arterial healing after injury and are in decreased number in arterial aneurysms. This cellular deficiency may account for poor healing capabilities and ongoing expansion of aneurysms. Methods: Aneurysmal aortic xenografts in rats displaying extracellular matrix injury by inflammation and proteolysis were seeded endoluminally with syngeneic VSMCs, with controls receiving culture medium only. Diameter, structure, and the destruction/reconstruction balance were assessed. Results: Eight weeks after endovascular infusion, aneurysmal diameter had increased further, from 3.0 ± 0.3 mm to 10.9 ± 6.5 mm (P = 0.009), and medial elastin content had decreased from 36.5 ± 8.5 to 5.2 ± 5.5 surface-percent (S%; P = 0.009) in controls, whereas these parameters remained stable in the seeded group (3.0 ± 0.3 to 2.7 ± 0.2 mm, P = 0.08; 36.5 ± 8.4 to 31.6 ± 9.7 S%, P = 0.22). VSMC seeding was followed by a decrease in mononuclear infiltration. MMP-1, -3, -7, -9, and -12 mRNA contents were sharply decreased in the diseased wall in response to seeding. Tissue inhibitor of metalloproteinase-1, -2, and -3 mRNAs in the intima were increased in a 2 to 10 magnitude in comparison with controls. Gelatin zymography showed the disappearance of MMP-9 activity and reverse zymography a strong increase in tissue inhibitor of metalloproteinase-3 activity in the seeded group. VSMC-seeded aneurysms were rich in collagen and lined with an endothelium instead of a thrombus in controls. Conclusions: VSMCs endovascular seeding restores the healing capabilities of proteolytically injured extracellular matrix in aneurysmal aortas, and stops expansion.
- 1 March 2004
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 239 (3) , 417-427
Vascular Smooth Muscle Cell Endovascular Therapy Stabilizes Already Developed Aneurysms in a Model of Aortic Injury Elicited by Inflammation and Proteolysis
Objective: To investigate the efficiency of endovascular smooth muscle cell (VSMC) seeding in promoting healing and stability in already-developed aneurysms obtained by matrix metalloproteases (MMPs)-driven injury. Summary Background Data: VSMCs are instrumental in arterial healing after injury and are in decreased number in arterial aneurysms. This cellular deficiency may account for poor healing capabilities and ongoing expansion of aneurysms. Methods: Aneurysmal aortic xenografts in rats displaying extracellular matrix injury by inflammation and proteolysis were seeded endoluminally with syngeneic VSMCs, with controls receiving culture medium only. Diameter, structure, and the destruction/reconstruction balance were assessed. Results: Eight weeks after endovascular infusion, aneurysmal diameter had increased further, from 3.0 ± 0.3 mm to 10.9 ± 6.5 mm (P = 0.009), and medial elastin content had decreased from 36.5 ± 8.5 to 5.2 ± 5.5 surface-percent (S%; P = 0.009) in controls, whereas these parameters remained stable in the seeded group (3.0 ± 0.3 to 2.7 ± 0.2 mm, P = 0.08; 36.5 ± 8.4 to 31.6 ± 9.7 S%, P = 0.22). VSMC seeding was followed by a decrease in mononuclear infiltration. MMP-1, -3, -7, -9, and -12 mRNA contents were sharply decreased in the diseased wall in response to seeding. Tissue inhibitor of metalloproteinase-1, -2, and -3 mRNAs in the intima were increased in a 2 to 10 magnitude in comparison with controls. Gelatin zymography showed the disappearance of MMP-9 activity and reverse zymography a strong increase in tissue inhibitor of metalloproteinase-3 activity in the seeded group. VSMC-seeded aneurysms were rich in collagen and lined with an endothelium instead of a thrombus in controls. Conclusions: VSMCs endovascular seeding restores the healing capabilities of proteolytically injured extracellular matrix in aneurysmal aortas, and stops expansion.